- Home
- AIXI vs TARA Comparison
AIXI vs TARA Comparison
Compare AIXI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIXI
- TARA
- Stock Information
- Founded
- AIXI 2001
- TARA N/A
- Country
- AIXI China
- TARA United States
- Employees
- AIXI N/A
- TARA N/A
- Industry
- AIXI Computer Software: Prepackaged Software
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIXI Technology
- TARA Health Care
- Exchange
- AIXI Nasdaq
- TARA Nasdaq
- Market Cap
- AIXI 61.2M
- TARA 52.4M
- IPO Year
- AIXI 2023
- TARA N/A
- Fundamental
- Price
- AIXI $4.94
- TARA $5.16
- Analyst Decision
- AIXI
- TARA Strong Buy
- Analyst Count
- AIXI 0
- TARA 3
- Target Price
- AIXI N/A
- TARA $22.67
- AVG Volume (30 Days)
- AIXI 102.9K
- TARA 6.6M
- Earning Date
- AIXI 12-24-2024
- TARA 11-12-2024
- Dividend Yield
- AIXI N/A
- TARA N/A
- EPS Growth
- AIXI N/A
- TARA N/A
- EPS
- AIXI N/A
- TARA N/A
- Revenue
- AIXI $65,643,604.00
- TARA N/A
- Revenue This Year
- AIXI $22.85
- TARA N/A
- Revenue Next Year
- AIXI $22.70
- TARA N/A
- P/E Ratio
- AIXI N/A
- TARA N/A
- Revenue Growth
- AIXI 6.22
- TARA N/A
- 52 Week Low
- AIXI $2.06
- TARA $1.60
- 52 Week High
- AIXI $22.05
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- AIXI 39.47
- TARA 60.39
- Support Level
- AIXI $5.34
- TARA $5.27
- Resistance Level
- AIXI $6.46
- TARA $6.39
- Average True Range (ATR)
- AIXI 0.53
- TARA 0.91
- MACD
- AIXI -0.13
- TARA 0.03
- Stochastic Oscillator
- AIXI 7.01
- TARA 33.50
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).